70%
of small molecule drugs fail to progress from Phase 2 to Phase 3 studies.
Mitigating Risk Across Biotech
At Imagine Biotech, we help biotech and pharmaceutical companies avoid one of the industry's most costly pitfalls: failing clinical trials without fully understanding their molecules.
Too often, traditional development is expensive, time consuming, and ultimately fails due to issues like poor solubility, off-target toxicity, or weak drug-enzyme interactions.
Our platform combines advanced computational modeling, molecular simulations, and quantum chemistry to provide a deep, predictive understanding of how compounds behave at early stages when clarity is most critical. This empowers more informed decisions and reduces technical risk to avoid costly pitfalls.
Backed by a world-class team of PhDs, Imagine Biotech delivers integrated, science-driven reports that accelerate development and protect capital.
We are building the future of drug discovery.
Our Services
1
Know Your Molecule™
Uncover molecular red flags via:
-
Advanced chemical analysis, AI structural analysis, and bioinformatics
-
Validation of mechanism of action
-
Toxicity analysis
-
Solubility analysis
-
Metabolite database access
2
ADMET Prediction & PK Modeling
Detect formulation challenges early
-
Integrate molecular data with physiological insights
-
Reduces late-stage failures, using six toxicity properties and Tox21 endpoints
3
CMC Advisory & Consulting
Prevent 40% of clinical holds
- Covers all aspects of drug development, from initial design to manufacturing to ensure consistent quality and compliance